During the height of the COVID-19 pandemic, many committees and organisations were working around the clock to prepare the country for the rollout of COVID-19 vaccines. Professor Hannelie Meyer, a pharmacist-turned-academic and later vaccine advocate, served on several of these committees. Elri Voigt spoke to Meyer about the pandemic, the mottos that guide her, and being an unapologetic workaholic.
Government can avoid the overwhelming of health services and minimise death in an anticipated fourth COVID-19 wave in November/December by getting 90% of people in South Africa over 35 years old vaccinated before then. Life could then return to normal by Christmas, even with ongoing SARS-CoV-2 circulation, contends vaccinologist Professor Shabir Madhi.
Phase two of South Africa’s COVID-19 vaccine rollout is underway and members of the public are being asked to report any mild, moderate or severe adverse events experienced after receiving their jabs. Adele Baleta explains what the correct way is to report adverse events after vaccination.
South Africa is vaccinating against COVID-19. Here are questions and answers about the vaccine.
The head of the South African arm of a key COVID-19 vaccine clinical trial is “full of pride” for the teams’ part in the research which has shown the vaccine candidate to be more than 90% effective according to early findings released this week. It however remains unclear whether the vaccine will be available in South Africa once registered. Adele Baleta reports.
A recent global online survey suggests that more than a third of South Africans would not want a COVID-19 vaccine if and when it becomes available. Adele Baleta reports on vaccine hesitancy in South Africa.
